VIATRIS INC (VIA.DE) Stock Price, Forecast & Analysis
Europe • Frankfurt Stock Exchange • FRA:VIA • US92556V1061
VIA.DE Key Statistics, Chart & Performance
The current stock price of VIA.DE is 12.23 EUR. In the past month the price increased by 14.46%. In the past year, price increased by 16.92%.
VIA.DE Technical Analysis
ChartMill assigns a technical rating of 9 / 10 to VIA.DE. When comparing the yearly performance of all stocks, VIA.DE is one of the better performing stocks in the market, outperforming 88.86% of all stocks.
VIA.DE Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to VIA.DE. Both the profitability and financial health of VIA.DE have multiple concerns.
VIA.DE Financial Highlights
Over the last trailing twelve months VIA.DE reported a non-GAAP Earnings per Share(EPS) of 1.97. The EPS decreased by -14.65% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -9.73% | ||
| ROE | -24.26% | ||
| Debt/Equity | 0.82 |
VIA.DE Forecast & Estimates
18 analysts have analysed VIA.DE and the average price target is 11.15 EUR. This implies a price decrease of -8.81% is expected in the next year compared to the current price of 12.23.
For the next year, analysts expect an EPS growth of -10.79% and a revenue growth -4.73% for VIA.DE
VIA.DE Ownership
VIA.DE Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| 1SAN | SANOFI | 9.69 | 197.812B | ||
| SAN | SANOFI | 9.61 | 197.667B | ||
| SNW | SANOFI | 9.67 | 197.353B | ||
| MRK | MERCK KGAA | 14.21 | 53.847B | ||
| UCB | UCB SA | 25.65 | 51.837B | ||
| UNC | UCB SA | 25.09 | 50.184B | ||
| 1BAYN | BAYER AG-REG | 9.24 | 44.371B | ||
| BAYN | BAYER AG-REG | 9.15 | 44.356B | ||
| IPN | IPSEN | 11.89 | 11.465B | ||
| TUB | FINANCIERE DE TUBIZE | N/A | 10.082B |
Related stock screener links
View all stocks in the Pharmaceuticals Industry | View all stocks in the Health Care Sector | View all stocks on the Frankfurt Stock Exchange Exchange | Find stocks with similar TA and Setup ratings on the European exchanges | Find stocks with similar Fundamental rating on the European exchanges | Find the competitors with the best technical ratings on the European exchanges | Find the competitors with the best fundamentals on the European exchanges | Find the competitors with the best valuation on the European exchanges | Find the competitors with the best dividend on the European exchanges | Find the competitors with the best analyst ratings on the European exchanges
About VIA.DE
Company Profile
Viatris, Inc. is a global healthcare company, which engages in the provision of healthcare and pharmaceutical products. The company is headquartered in Canonsburg, Pennsylvania and currently employs 32,000 full-time employees. The firm's segments include Developed Markets, Greater China, JANZ, and Emerging Markets. The Developed Markets segment comprises its operations primarily in North America and Europe. The Greater China segment includes its operations in China, Taiwan and Hong Kong. The JANZ segment reflects its operations in Japan, Australia, and New Zealand. The Emerging Markets segment encompasses its presence in more than 125 countries with developing markets and emerging economies, including in Asia, Africa, Eastern Europe, Latin America, and the Middle East, as well as the Company’s Antiretroviral medicines (ARV) franchise. Its pipeline and research and development capabilities include expertise in formulation, device development, toxicology, analytical, clinical, bioanalytical, medical affairs, product safety and risk management across a range of therapeutic areas. The company produces oral solid doses, injectables, and products with complex dosage forms.
Company Info
VIATRIS INC
1000 Mylan Boulevard
Canonsburg PENNSYLVANIA US
Employees: 32000
Phone: 17245141465
VIATRIS INC / VIA.DE FAQ
What does VIA do?
Viatris, Inc. is a global healthcare company, which engages in the provision of healthcare and pharmaceutical products. The company is headquartered in Canonsburg, Pennsylvania and currently employs 32,000 full-time employees. The firm's segments include Developed Markets, Greater China, JANZ, and Emerging Markets. The Developed Markets segment comprises its operations primarily in North America and Europe. The Greater China segment includes its operations in China, Taiwan and Hong Kong. The JANZ segment reflects its operations in Japan, Australia, and New Zealand. The Emerging Markets segment encompasses its presence in more than 125 countries with developing markets and emerging economies, including in Asia, Africa, Eastern Europe, Latin America, and the Middle East, as well as the Company’s Antiretroviral medicines (ARV) franchise. Its pipeline and research and development capabilities include expertise in formulation, device development, toxicology, analytical, clinical, bioanalytical, medical affairs, product safety and risk management across a range of therapeutic areas. The company produces oral solid doses, injectables, and products with complex dosage forms.
What is the stock price of VIATRIS INC today?
The current stock price of VIA.DE is 12.23 EUR. The price increased by 4.57% in the last trading session.
Does VIATRIS INC pay dividends?
VIATRIS INC (VIA.DE) has a dividend yield of 3.67%. The yearly dividend amount is currently 0.4.
How is the ChartMill rating for VIATRIS INC?
VIA.DE has a ChartMill Technical rating of 9 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
Where is VIATRIS INC (VIA.DE) stock traded?
VIA.DE stock is listed on the Frankfurt Stock Exchange exchange.
Would investing in VIATRIS INC be a good decision?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on VIA.DE.
Can you provide the market cap for VIATRIS INC?
VIATRIS INC (VIA.DE) has a market capitalization of 14.09B EUR. This makes VIA.DE a Large Cap stock.